The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued ...
The FDA recalled 60 doughnut products, totaling more than 2 million cases, for potential listeria contamination. The ...
The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause ...
The Associated Press on MSN9d
FDA approves first new class of painkiller in 20 years, a non-addictive opioid alternativeThe medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Martha Stewart Living on MSN3d
Chocolate Recall Considered Class I Due to 'Deadly' Allergen Risk, FDA WarnsIn December, the United States Food and Drug Administration (FDA) announced a recall on various chocolate products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback